Churg-strauss syndrome associated with fluticasone therapy

Archives of Dermatology

Volumn 137, Issue 11, 2001, Pages 1527-1528

  Termeer, C ^a   Simon, J C ^a   Schopf E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETAMETHASONE; BUDESONIDE; CLOBETASOL PROPIONATE; CROMOGLYCATE DISODIUM; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; MONTELUKAST; PREDNISOLONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE; ZAFIRLUKAST;

CASE REPORT; CHRONIC BRONCHITIS; CHURG STRAUSS SYNDROME; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHILIA; HUMAN; LUNG INFECTION; MALE; NOTE; PATCH TEST; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035169352     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.137.11.1527     Document Type: Note

References (6)

1. Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement
2. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma
3. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment
4. Churg-Strauss syndrome: Serum markers of lymphocyte activation and endothelial damage
5. Churg-Strauss syndrome: Is there an association with leukotriene modifiers?
6. Adverse reactions to N-acetylcysteine